camostat has been researched along with phenylalanine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mann, GE; Muñoz, M | 1 |
| Agudelo, J; Barnard, D; Carrion, R; Lu, K; McKerrow, JH; Nunneley, JW; Pöhlmann, S; Renslo, AR; Simmons, G; Vedantham, P; Zhou, Y | 1 |
2 other study(ies) available for camostat and phenylalanine
| Article | Year |
|---|---|
Adaptation of pancreatic amino acid transport in rats after treatment with the synthetic protease inhibitor camostat mesilate.
Topics: Administration, Oral; Amino Acids; Animals; Esters; Gabexate; Guanidines; Male; Pancreas; Phenylalanine; Protease Inhibitors; Rats; Rats, Inbred Strains | 1989 |
Protease inhibitors targeting coronavirus and filovirus entry.
Topics: Animals; Antiviral Agents; Cathepsins; Cell Line, Tumor; Coronavirus; Coronavirus Infections; Dipeptides; Ebolavirus; Esters; Filoviridae; Gabexate; Guanidines; Humans; Mice; Mice, Inbred BALB C; Phenylalanine; Piperazines; Protease Inhibitors; Serine Endopeptidases; Serine Proteinase Inhibitors; Severe acute respiratory syndrome-related coronavirus; Tosyl Compounds; Vinyl Compounds; Virus Internalization | 2015 |